RLF-MYCL fusion: A new tool for treatment of small cell lung cancer
- PMID: 34854230
- PMCID: PMC8720625
- DOI: 10.1111/1759-7714.14253
RLF-MYCL fusion: A new tool for treatment of small cell lung cancer
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer.Cancer Discov. 2021 Dec 1;11(12):3214-3229. doi: 10.1158/2159-8290.CD-21-0441. Cancer Discov. 2021. PMID: 34344693 Free PMC article.
-
The molecular approach to diagnosis in lung cancer.Br J Hosp Med (Lond). 2015 May;76(5):C74-6. doi: 10.12968/hmed.2015.76.5.C74. Br J Hosp Med (Lond). 2015. PMID: 25959953 No abstract available.
-
PLEKHM2-ALK: A novel fusion in small-cell lung cancer and durable response to ALK inhibitors.Lung Cancer. 2020 Jan;139:146-150. doi: 10.1016/j.lungcan.2019.11.002. Epub 2019 Nov 6. Lung Cancer. 2020. PMID: 31794921
-
[The molecular pathogenesis of small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2010 Nov;13(11):C46-57. doi: 10.3779/j.issn.1009-3419.2010.11.18. Zhongguo Fei Ai Za Zhi. 2010. PMID: 21081036 Free PMC article. Review. Chinese. No abstract available.
-
myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.Princess Takamatsu Symp. 1991;22:307-18. Princess Takamatsu Symp. 1991. PMID: 1668890 Review.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer. 2021;71(3):209–49. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical